Related references
Note: Only part of the references are listed.Low-Molecular-Weight Heparin Overdose: Management by Observation
Andrew A. Monte et al.
ANNALS OF PHARMACOTHERAPY (2010)
Polysaccharide-Modified Synthetic Polymeric Biomaterials
Aaron D. Baldwin et al.
BIOPOLYMERS (2010)
Anticoagulant Efficacy of Solid Oral Formulations Containing a New Heparin Derivative
Jin Woo Park et al.
MOLECULAR PHARMACEUTICS (2010)
Toward Effective Long-Term Prevention of Thromboembolism: Novel Oral Anticoagulant Delivery Systems
Miha Homar et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2010)
Comparative Pharmacodynamics and Pharmacokinetics of Oral Direct Thrombin and Factor Xa Inhibitors in Development
Bengt I. Eriksson et al.
CLINICAL PHARMACOKINETICS (2009)
59: Low Molecular Weight Heparin Overdose
A.S. Ngo et al.
ANNALS OF EMERGENCY MEDICINE (2008)
Injectable hydrogels as unique biomedical materials
Lin Yu et al.
CHEMICAL SOCIETY REVIEWS (2008)
Pharmacology and management of the vitamin K antagonists
Jack Ansell et al.
CHEST (2008)
Antithrombotic therapy in neonates and children
Paul Monagle et al.
CHEST (2008)
Triggers, targets and treatments for thrombosis
Nigel Mackman
NATURE (2008)
Differentiating low-molecular-weight heparins based on chemical, biological, and pharmacologic properties: Implications for the development of generic versions of low-molecular-weight heparins
Walter P. Jeske et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2008)
Pharmacokinefics and pharmalcodynamics of oral heparin solid dosage form in healthy human subjects
Shaker A. Mousa et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Production of heparin-functionalized hydrogels for the development of responsive and controlled growth factor delivery systems
Ting Nie et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Effects of neighboring sulfides and pH on ester hydrolysis in thiol-acrylate photopolymers
Amber E. Rydholm et al.
ACTA BIOMATERIALIA (2007)
Novel in situ forming, degradable dextran hydrogels by Michael addition chemistry: Synthesis, rheology, and degradation
Christine Hiemstra et al.
MACROMOLECULES (2007)
Oral, direct Factor Xa inhibitors in development for the prevention and treatment of thromboembolic diseases
Alexander G. G. Turpie
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Beyond heparin and warfarin: the new generation of anticoagulants
Jeffrey I. Weitz et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2007)
Projections of global mortality and burden of disease from 2002 to 2030
Colin D. Mathers et al.
PLOS MEDICINE (2006)
Controlling network structure in degradable thiol-acrylate biomaterials to tune mass loss behavior
Amber E. Rydholm et al.
BIOMACROMOLECULES (2006)
Oral bioavailability of a low molecular weight heparin using a polymeric delivery system
Valerie Hoffart et al.
JOURNAL OF CONTROLLED RELEASE (2006)
被撤回的出版物: Evaluation of the oral bioavailability of low molecular weight heparin formulated with glycyrrhetinic acid as permeation enhancer (Retracted article. See vol. 69, pg. 535, 2008)
Nusrat A. Motlekar et al.
DRUG DEVELOPMENT RESEARCH (2006)
Polycationic lipophilic-core dendrons as penetration enhancers for the oral administration of low molecular weight heparin
PY Hayes et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
PEG-cross-linked heparin is an affinity hydrogel for sustained release of vascular endothelial growth factor
G Tae et al.
JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION (2006)
PEGylation, successful approach to drug delivery
FM Veronese et al.
DRUG DISCOVERY TODAY (2005)
Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor
SS Cai et al.
BIOMATERIALS (2005)
Drug therapy -: Direct thrombin inhibitors
M Di Nisio et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Modeling of network degradation in mixed step-chain growth polymerizations
SK Reddy et al.
POLYMER (2005)
The effect of the linker on the hydrolysis rate of drug-linked ester bonds
RG Schoenmakers et al.
JOURNAL OF CONTROLLED RELEASE (2004)
In situ crosslinkable hyaluronan hydrogels for tissue engineering
XZ Shu et al.
BIOMATERIALS (2004)
The pharmacology and management of the vitamin K antagonists
J Ansell et al.
CHEST (2004)
Preparation of cross-linked hyaluronic acid film using 2-chloro-1-methylpyridinium iodide or water-soluble 1-ethyl-(3,3-dimethylaminopropyl)carbodiimide
JJ Young et al.
JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION (2004)
Synthesis and physicochemical characterization of end-linked poly(ethylene glycol)-co-peptide hydrogels formed by Michael-type addition
MP Lutolf et al.
BIOMACROMOLECULES (2003)
Protein-heparin interactions measured by BIAcore 2000 are affected by the method of heparin immobilization
RIW Osmond et al.
ANALYTICAL BIOCHEMISTRY (2002)
Efficacy of minocycline and EDTA lock solution in preventing catheter-related bacteremia, septic phlebitis, and endocarditis in rabbits
I Raad et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Hydrogels for biomedical applications
AS Hoffman
ADVANCED DRUG DELIVERY REVIEWS (2002)
In vitro and in vivo evaluation of oral heparin-loaded polymeric nanoparticles in rabbits
YY Jiao et al.
CIRCULATION (2002)
Heparin and low-molecular-weight heparin - Mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety
J Hirsh et al.
CHEST (2001)
Differential reactivity of maleimide and bromoacetyl functions with thiols: Application to the preparation of liposomal diepitope constructs
P Schelte et al.
BIOCONJUGATE CHEMISTRY (2000)
Share Paper
